CRL
CRL
NYSE · Life Sciences Tools & Services

Charles River Laboratories

$279.01
+0.95 (+0.34%)
As of Sep 21, 9:46 PM ET ·
Day Range $275.88 — $281.63
52W Range $144.26 — $303.31

Performance

1D
1W
1M
3M
6M
1Y +81.30%
YTD +37.84%
Open$279.37
Previous Close$278.06
Day High$281.63
Day Low$275.88
52W High$303.31
52W Low$144.26
Volume
Avg Volume862.9K
Market Cap13.45B
P/E Ratio
EPS$-4.85
SectorLife Sciences Tools & Services

Technical Indicators

Full analysis →
SMA 50 $200.46 Above
SMA 200 $169.92 Above
RSI (14) 21.1 Oversold
Trend Golden Cross Bullish

Analyst Ratings

Buy
23 analysts
17 Buy 6 Hold 0 Sell
Price Target -74.5% upside
Current
$279.01
Target
$71.21
$57.45 $71.21 avg $105.86

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 3.92B 3.90B 1.98B
Net Income -140,830,079 -126,330,181 304.29M
Profit Margin -3.6% -3.4% 15.4%
EBITDA 199.26M 188.68M 664.62M
Free Cash Flow 311.82M
Rev Growth +0.3% +0.3% +16.2%
Debt/Equity 0.68 0.68 0.57

Life Sciences Tools & Services Peers

Symbol Name Price Change P/E Mkt Cap
TMO Thermo Fisher Scientific Inc $658.76 +1.12% 34.9 243.41B
DHR Danaher Corp $215.84 +1.90% 36.6 146.47B
A Agilent Technologies Inc $161.94 +3.50% 29.4 42.29B
IQV Iqvia Holdings Inc $269.88 +1.30% 32.3 44.35B
MTD Mettler-Toledo International $1,430.44 +2.74% 31.2 28.26B
WAT Waters Corp $423.92 +0.54% 241.5 40.12B